Proteins, Pathogens, and Failure at the Composite-Tooth Interface

In the United States, composites accounted for nearly 70% of the 173.2 million composite and amalgam restorations placed in 2006 (Kingman et al., 2012), and it is likely that the use of composite will continue to increase as dentists phase out dental amalgam. This trend is not, however, without consequences. The failure rate of composite restorations is double that of amalgam (Ferracane, 2013). Composite restorations accumulate more biofilm, experience more secondary decay, and require more frequent replacement. In vivo biodegradation of the adhesive bond at the composite-tooth interface is a major contributor to the cascade of events leading to restoration failure. Binding by proteins, particularly gp340, from the salivary pellicle leads to biofilm attachment, which accelerates degradation of the interfacial bond and demineralization of the tooth by recruiting the pioneer bacterium Streptococcus mutans to the surface. Bacterial production of lactic acid lowers the pH of the oral microenvironment, erodes hydroxyapatite in enamel and dentin, and promotes hydrolysis of the adhesive. Secreted esterases further hydrolyze the adhesive polymer, exposing the soft underlying collagenous dentinal matrix and allowing further infiltration by the pathogenic biofilm. Manifold approaches are being pursued to increase the longevity of composite dental restorations based on the major contributing factors responsible for degradation. The key material and biological components and the interactions involved in the destructive processes, including recent advances in understanding the structural and molecular basis of biofilm recruitment, are described in this review. Innovative strategies to mitigate these pathogenic effects and slow deterioration are discussed.

Non-preference for oviposition and antibiosis in bean cultivars to Bemisia tabaci biotype B (Hemiptera: Aleyrodidae)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Prevalência da excreção e caracterização molecular do poliomavírus humano JC em amostras de urina de pacientes com aids sem leucoencefalopatia multifocal pro-gressiva

The human poliomavirus is the etiologic agente of Progressive multifocal leukoencephalopathy (PML), a disease characterized by focal lesions not expansives of the central nervous system that develops in imunocompromissed patients, specially people with aids. The main aim of the study was to evalute the prevalence of the JCV excretion in urine samples of patients with aids, without PML, to compare two JCV DNA detection techniques through of two diferents genomic regions and to evaluate the genotypic characterization of the positive samples. A total of 75 samples were colected in the Instituto de Infectologia Emílio Ribas, in Sao Paulo, Brazil, between may and november, 2009. To detect the JC virus it was made the DNA extraction and then the polimerase chain reaction (PCR). Firstly a fragment of 215 bp was amplified, which corresponds to the codifying gene of the strutural protein of de JC vírus capsid VP1. All the samples were later submitted to another PCR that uses a pair of primers complementaries to the early region of the JCV (T antigen) amplifying a fragment of 173 bp. Followed by the digestion of the amplified product with the restriction enzime BamH1, resulting in two smaller fragments (120 bp and 53 bp). The JC vírus was detected in 53 samples, for both techniques (70,7% for VP1 PCR, and the restriction enzime BamH1), 34/46 were men (73,9%) and 19/29 were women (65,5%). The JCV excretion was higher in individuals that were over 46 years old. Regarding the seven genotypes described in the literature, the ones that were more prevalent among the JC positive patients were 3B and 3A with 10 samples each (21,0%), the 2B with 9 samples (19,0%) and genotype 6, with six samples (13,0%). As in the brown patients as the white ones, the most prevalent genotype was 3B. In the present study it was observed a high prevalence of JCV DNA (70,7%) and the genotype 3 (43,0%)... (Complete abstract click electronic access below)

Rerrefino de óleo lubrificante usado

The lubricant oil used in engines of internal combustion must be, periodically, changed. Its mainly function in the engines is to reduce the friction between the pieces, but its presence also promotes the cleanness and the refrigeration of the equipment. These attributions, at the end of some cycles of operation, make the oil to be dirty, that is, full of contaminating substances such as water, gasoline, diesel, additives, oxidized hydro-carbons and rests of metals, not being recommended, therefore, its discarding in the environment. Thus, all the used lubricant oil that leaves the automobiles engine has been thrust, waiting for a solution. The pollution generated by the discarding of a ton of used oil per day in the soil or in the rivers is equivalent to a domestic sewer of 40 thousand of people. The indiscriminate burning of the used lubricant oil generates significant emissions of metallic oxides, besides other toxic gases, like the dioxin and sulphur oxides. In this context, the mean objective of this essay was to effectuate the rerrefine of the used lubricant oil, aiming the increase of its life cycle and consequently contributing for the reduction of the environmental pollution. According to the used process, it was possible to get a rerrefine oil, of good quality, which physicistchemistries properties are in compliance with the norms of NBR and ASTM

Diagnóstico molecular da alteração mutagênica nt 230 (del4) no gene MDR1 em cães

P-glycoprotein is an adenosine triphosphate (ATP)-driven drug efflux carrier responsible for transport of xenobiotics and multiple classes of drugs, many usually use in veterinary medicine. Encoded by MDR1 gene, also referred to as ABCB1, located on chromosome 14, is expressed in many tissues with secretory or excretory functions, such as liver, kidney and intestine, where it limits drug absorption from the gut and promotes drug excretion into the bile and urine of their substrates. In 2001, a 4 base pair gene deletion mutation in the canine MDR1 gene was identified as MDR1-1▲, ABCB1-1▲, MDR1 MDR1 nt 230 (del4) and associated with an non-functional Pglycoprotein. The clinical correlation is the (hyper) sensitivity of certain dogs breeds, mostly collies, to a few classes of drugs such as anticancer drugs (doxorubicin, vincristine, vinblastine), immunosuppressants (cyclosporine), antiparasitic drugs (ivermectin, moxidectin), steroids hormones (aldosterone, cortisol, dexamethasone), antimicrobial agents (tetracycline, doxycycline, levofloxacin, ketoconazole, itraconazole), analgesics (morphine, methadone), antidiarrheals (loperamide), antiepileptic agents (phenothiazine), cardiac drugs (digoxin, diltiazem, verapamil, talinolol) and others. Dogs with homozygous MDR1 nt 230 (del4) MDR1 mutations (MDR1 - / -) have a higher predisposition to intoxication with substrates of P-gp than heterozygous (MDR1 + / -) and these are more likely than dogs homozygous nonmutant (MDR1 +/ +). After the identification of nt230 (del4) mutation, several molecular techniques have been developed for identification of mutant animals as a diagnostic method. The importance of molecular diagnosis is, after the identification of mutant animals, establish treatment protocols safe, exclude this animals from reproduction (genetic selection program) and investigating the history of adverse drugs reactions... (Complete abstract click electronic access below)

Cinética de hidrólise de GPTS sob estimulação ultrassônica

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Bioatividade de cipó-prata (Trigonia nivea Cambess) sobre a excreção renal de água e eletrólitos e pressão arterial

Brazil is a country with the largest world´s vegetal genetic diversity and the Environmental Protection Area (APA) of the “Serra da Mantiqueira” is a very heterogeneous region, representing one of the richest sources of pharmacologically actives materials. The population uses medicinal plants and according to the OMS, 80% of the population uses them in primary treatment of several diseases. Nevertheless, the loss of traditional knowledge associated with medicinal plants is occurring quickly. The ethnopharmacological strategy uses traditional knowledge to the search for medicinal plants that can have bioactive substances against diseases that afflicting the population and thus protect traditional knowledge. The “cipó-prata” (Trigonia nívea Cambess.) is a native plant normally found in the “Bacia do Paraná” region and present in the flora in the neighborhood of “Marins”, Piquete-SP and usually, said for the treatment of renal and urinary diseases. So, the objective of this study was test if the “cipóprata” (Trigonia nívea Cambess.) has effects on the renal excretion of water and salt, in anesthetized Wister rats. The tests were made in males Wistar rats and randomly distributed into 4 experimental groups: Group I – aqueous control, Group II – treated with aqueous extract (EA) of “cipó-prata”, Group III – water control + “tween 80”, Group IV – treated with ethanol extract (EE) and “cipó-prata”. All groups were subjected to experimental protocol, composed of three periods: Balance (40 minutes), Basal (30 minutes) and Experimental (90 minutes), occurring the urine collection every 30 minutes, from the basal period and measuring blood pressure every 10 minutes. The aqueous extract (EA) of “cipó-prata” (Trigonia nívea Cambess.) presented diuretic effect of 173% (B-2,4±1,19 μL/min reaching 6,6±1,45 μL/min, in the period EX3) and ...(Complete abstract click electronic access below)

Insuficiência renal crônica em cães

The kidneys, for his anatomical and functional characteristics, are sensitive to affections that take the liberation of renal toxins or the blood supply, causing irreversible injuries to his renoparenchymal tissue that is substituted by fibrous tissue. Even after the resolution of the basic cause, there will be the loss of a significant number of his functional unity, renal adaptations will take place in the attempt of maintaining the renal function. These adaptations produce additional injuries, perpetuating to loss of renoparenchymal tissue and the reduction of the renal function. The renal insufficiency (IR) takes place after the loss of 3/4 of the number of his functional unities. Before the progression to the phase of IR, the animal shows up practically without symptoms, but for the gradual increase of the urinary and of the ingestion of water. The reduction of the degree of renal function leads to alterations system compensatory for the accumulation of substances that would suffer renal excretion. The progression of IR leads to the phase of the syndrome urêmica. In this phase the animal presents innumerable clinical signs that can take it to the death. The treatment is symptomatic and dietetic, but depending on the phase not much efficient. Because of being progressive and insidious, the IRC demands the preparation of campaigns and programs of explanation for the veterinary doctors who aim for the consciousness and/or sensibility of the owners to carry out periodic examinations of selection that precociously detect the renal dysfunction. The diagnosis in the beginning IR enables the efficiency of the treatment in stop or slowing his progression, extending the time and quality of life of the patient